Publications
Co-Author, “Mitigating AI Risks in Pharma Needs a New Governance Framework,” Bloomberg Law Insights, September 27, 2024
Co-Author, “Key Corporate Governance Strategies for Mitigating AI-related Legal Risks in the Pharmaceutical Industry,” Bloomberg Law Perspectives, September 4, 2024
Co-Author, “The Impact on Equity Compensation Tax Withholding of the SEC’s New T+1 Settlement Cycle,” Insights: The Corporate and Securities Law Advisor, August 2024
Co-Author, “Equity Rights Offering Considerations as Maturity Cliff Looms,” Law360, July 15, 2024